OTCMKTS:IZOZF Izotropic (IZOZF) Stock Price, News & Analysis → AI Bubble Now at Critical Mass (From Porter & Company) (Ad) Free IZOZF Stock Alerts $0.10 0.00 (0.00%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$0.10▼$0.1050-Day Range$0.08▼$0.1452-Week Range$0.05▼$0.36Volume5,400 shsAverage Volume24,648 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Izotropic alerts: Email Address Ad Porter & CompanyAI Bubble Now at Critical MassWashington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.Simply click here now to read The Big AI Die-Up. About Izotropic Stock (OTCMKTS:IZOZF)Izotropic Corporation, a medical device company, develops and commercializes diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a 360-degree computed tomography imaging system designed for breast imaging. The company was incorporated in 2016 and is headquartered in Surrey, Canada.Read More IZOZF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart IZOZF Stock News HeadlinesMarch 22, 2024 | americanbankingnews.comIzotropic (OTCMKTS:IZOZF) Shares Up 22.2%January 30, 2024 | finance.yahoo.comIzotropic Receives Response From U.S. FDAMarch 28, 2024 | Porter & Company (Ad)AI Bubble Now at Critical MassWashington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.January 8, 2024 | finance.yahoo.comIzotropic Provides Regulatory and Operational UpdatesNovember 11, 2023 | morningstar.comIzotropic Corp IZONovember 9, 2023 | morningstar.comIzotropic Corp IZOZFNovember 1, 2023 | finanznachrichten.deIzotropic Corporation: Izotropic Completes Pre-Submission Meeting with U.S. FDANovember 1, 2023 | finance.yahoo.comIzotropic Completes Pre-Submission Meeting with U.S. FDAMarch 28, 2024 | Porter & Company (Ad)AI Bubble Now at Critical MassWashington, D.C., has just issued its first round of new artificial-intelligence (“AI”) regulations. And a flood of additional AI bills is making its way through Congress. Nasdaq reports this could bring a screeching halt to the AI stock boom.September 27, 2023 | finance.yahoo.comIzotropic Confirms FDA Pre-Submission Meeting DateSeptember 20, 2023 | finance.yahoo.comIzotropic Closes Non-Brokered Private PlacementSeptember 6, 2023 | finance.yahoo.comIzotropic Files Class II Pre-Submission with FDA & Releases Details on Predicate DevicesJune 20, 2023 | finance.yahoo.comIzotropic Modifies Market Approval Pathway & StrategyJune 8, 2023 | finance.yahoo.comIzotropic CEO ResignsMarch 17, 2023 | ca.finance.yahoo.comIzotropic Corporation (IZOZF)February 23, 2023 | finance.yahoo.comIzotropic's Technical & Scientific Team Members Advocate for Commercialization of Breast CT TechnologyFebruary 22, 2023 | finance.yahoo.comIzotropic Corporation (IZOZF) Stock Historical Prices & Data - Yahoo FinanceFebruary 19, 2023 | marketwatch.comIsotropic Graphite Market is Expected to Experience an Upward Trend in Terms of Growth and Expansion Forecast 2028January 9, 2023 | finance.yahoo.comIzotropic Releases First Video of IzoViewJanuary 5, 2023 | ca.finance.yahoo.comIzotropic Corporation (IZO.CN)January 4, 2023 | finance.yahoo.comIzotropic Reports Board Meeting ResultsDecember 1, 2022 | finanznachrichten.deIzotropic Corporation: Izotropic Completes IzoView Development and Assembly, Prepares for Final TestingDecember 1, 2022 | finance.yahoo.comIzotropic Completes IzoView Development and Assembly, Prepares for Final TestingNovember 11, 2022 | finanznachrichten.deIzotropic Corporation: Alexander Tokman Joins Izotropic Board of DirectorsNovember 11, 2022 | finance.yahoo.comAlexander Tokman Joins Izotropic Board of DirectorsOctober 25, 2022 | finance.yahoo.comIzotropic's IzoView Is Weeks Away from Final Engineering & Showcasing to Investment and Scientific CommunitiesAugust 11, 2022 | finance.yahoo.comIzotropic Finalizes Engineering and Development Transition to the United States; Establishes Operations in Primary Target MarketSee More Headlines Receive IZOZF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Izotropic and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)3/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolOTCMKTS:IZOZF CUSIPN/A CIKN/A Webizocorp.com Phone833-496-2677FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Robert Louis Thast (Age 70)Founder, Interim CEO & Chairman Comp: $163.59kMr. Ralph F. Proceviat CPA (Age 74)Director & Interim CFO Dr. Younes Achkire Ph.D.Executive VP of Product Engineering & COOMr. Ali Reza SodagarLegal Advisor & Independent DirectorMs. Jaclyn ThastOperations Manager & Corporate SecretaryKey CompetitorsANGLEOTCMKTS:ANPCYbioAffinity TechnologiesNASDAQ:BIAFWEpigenomicsOTCMKTS:EPGNYEternity HealthcareOTCMKTS:ETAHIntegral DiagnosticsOTCMKTS:ITGDFView All Competitors IZOZF Stock Analysis - Frequently Asked Questions How have IZOZF shares performed in 2024? Izotropic's stock was trading at $0.0782 at the start of the year. Since then, IZOZF shares have increased by 27.9% and is now trading at $0.10. View the best growth stocks for 2024 here. Are investors shorting Izotropic? Izotropic saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 1,400 shares, a drop of 71.4% from the February 29th total of 4,900 shares. Based on an average daily volume of 20,200 shares, the short-interest ratio is presently 0.1 days. View Izotropic's Short Interest. When is Izotropic's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Sunday, March 31st 2024. View our IZOZF earnings forecast. How do I buy shares of Izotropic? Shares of IZOZF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:IZOZF) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeGrab Your Free Bitcoin Today!Crypto Swap ProfitsTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingFed launches fourth dollar overhaulStansberry ResearchForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Izotropic Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.